All things considered, H19, lncRNA HOTTIP, lncRNA CRNDE and lncRNA AGAP2–AS1 are potential therapeutic targets for improving HCC by inhibiting migration, invasion and EMT. The gene discussed is HOTTIP; the disease is hepatocellular carcinoma.